The molecular defect in the renal sodium‐phosphate transporter expression pathway of Gyro (Gy) mice is distinct from that of hypophosphatemie (Hyp) mice

Two animal models of the human dis‐order hypophosphatémie vitamin D‐resistant rickets exist, the Hyp and Gy mice. Affected mice and humane both manifest an X‐linked phenotype, and show decreased Na+/Pi transport activity in the renal proximal tubules, which is characterized by a decreased maximal velocity (Vmax). The defect in Hypmice is most likely due to a decreased transcription rate of the regal Na+/Pi transporter gene. The cur‐rent studies were designed to define the molecular defect in the Gy mice. Sodium‐dependent uptake of phosphate (Pi) in renal BBMV showed uptake levels of 170.58 ± 25 and 66.00 ±11 pmoling protein−1 6 s−1 in normal and Gy mice, respectively (n=3, P=0.0102). Glucose uptake levels in the BBMV were 1.94 ±0.87 and 1.91 ±0.35 pmol·mg protein−1·6 s−1 in normal and Gy mice, respectively (n=3). Northern blot analysis of kidney cortex in both mice revealed nearly equivalent message levels (normal/Gy = 1.01 ± 0.12, n=3). In situ hybridization localized the mRNA to the renal cortex in both mice and confirmed equal message levels. Western blot analysis of renal BBM proteins, using a polyclonal antiserum, showed one predominant band at 87 kDa in both mouse samples, with intensities being de‐creased in the Gy mice (normal/Gy=4.129 ± 0.70, n=4, P< 0.04). Immunohistochemical analysis localized the protein to the apical membrane of proximal tubules in both mice. These results suggest that the molecular defect in the Gy mice is distinct from that in the Hyp mice, and furthermore, that the manifestation of the diseased phenotype in Gy mice is related to a different defect in the renal Na+/Pi transporter expression pathway. The molecular mechanism of the defect likely relates to protein processing, metabolic turnover rate, or translocation to the brush‐border membrane. These results further suggest that two distinct X‐linked factors modulate different steps in the expression pathway of the Na+/Pi transporter gene.—Collins, J. F., Ghishan, F. K. The molecular defect in the renal sodium‐phosphate transporter expression pathway of Gyro (Gy) mice is distinct from that of hypophosphatémie (Hyp) mice. FASEBJ. 10, 751‐759 (1996)

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Collins,et al.  Decreased transcription of the sodium-phosphate transporter gene in the hypophosphatemic mouse. , 1995, The American journal of physiology.

[3]  J. Collins,et al.  Sodium-phosphate transporter adaptation to dietary phosphate deprivation in normal and hypophosphatemic mice. , 1995, The American journal of physiology.

[4]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[5]  J. Collins,et al.  Molecular cloning, functional expression, tissue distribution, and in situ hybridization of the renal sodium phosphate (Na+/Pi) transporter in the control and hypophosphatemic mouse , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Butler,et al.  Chromosomal Localization of the Human Renal Sodium Phosphate Transporter to Chromosome 5: Implications for X-Linked Hypophosphatemia , 1994, Pediatric Research.

[7]  F. Ghishan,et al.  Low Phosphate Diet Upregulates the Renal and Intestinal Sodium-Dependent Phosphate Transporter in Vitamin D–Resistant Hypophosphatemic Mice , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  A. Werner,et al.  Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets. Molecular characterization. , 1994, The Journal of clinical investigation.

[9]  F. Ghishan,et al.  Transport of Phosphate by Plasma Membranes of the Jejunum and Kidney of the Mouse Model of Hypophosphatemic Vitamin D-Resistant Rickets , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  R. Meyer,et al.  Craniofacial abnormalities in mice with X-linked hypophosphatemic genes (Hyp or Gy). , 1991, Teratology.

[11]  N. Nakagawa,et al.  Characterization of the defect in the Na(+)-phosphate transporter in vitamin D-resistant hypophosphatemic mice. , 1991, The Journal of biological chemistry.

[12]  R. Quock,et al.  Rearing and step climbing behavior of X-linked hypophosphatemic (Hyp) mice , 1987, Physiology & Behavior.

[13]  M. Lyon,et al.  The Gy mutation: another cause of X-linked hypophosphatemia in mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Hammerman,et al.  Pi transport, phosphorylation, and dephosphorylation in renal membranes from HYP/Y mice. , 1983, The American journal of physiology.

[15]  R. Gray,et al.  Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. , 1980, Endocrinology.

[16]  S. Goldfarb,et al.  Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets. , 1979, The Journal of clinical investigation.

[17]  F. Glorieux,et al.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Ehrlich,et al.  The Metabolic Basis Of Inherited Disease. , 1973 .

[19]  S. Ohno,et al.  Ancient Linkage Groups and Frozen Accidents , 1973, Nature.

[20]  A. George The metabolic basis of inherited disease , 1961 .

[21]  R. Winters,et al.  A GENETIC STUDY OF FAMILIAL HYPOPHOSPHATEMIA AND VITAMIN D RESISTANT RICKETS WITH A REVIEW OF THE LITERATURE , 1958, Medicine.

[22]  F. Albright,et al.  Rickets resistant to vitamin D therapy. , 1937 .

[23]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[24]  I. Bab,et al.  Patterns of matrix vesicle calcification in osteomalacia of Gyro mice. , 1982, Metabolic bone disease & related research.